Filter
4510
Filtered Results: 4510
Text search:
use
of
medicines
Featured
Recommendations
475
New Publications
1247
Language
Document type
No document type
2356
Studies & Reports
763
Guidelines
637
Manuals
255
Strategic & Response Plan
196
Fact sheets
115
Training Material
78
Situation Updates
47
Brochures
20
Resource Platforms
19
Infographics
12
Online Courses
10
Videos
2
Countries / Regions
India
235
Global
184
Kenya
147
South Africa
112
Ethiopia
103
Uganda
101
Nepal
90
Sierra Leone
89
Africa
87
Western and Central Europe
85
Liberia
83
Nigeria
83
Malawi
73
Myanmar / Burma
71
Ghana
70
Tanzania
69
Bangladesh
68
Zambia
67
Ukraine
61
Latin America and the Carribbean
59
Rwanda
54
Syria
45
Namibia
43
Congo, Democratic Republic of
39
Philippines
39
Eastern Europe
37
South–East Asia Region
34
Zimbabwe
33
Asia
27
Mozambique
25
Haiti
23
East and Southern Africa
23
West and Central Africa
23
Cambodia
22
Lesotho
22
Venezuela
22
Guinea
21
South Sudan
21
Botswana
21
Middle East and North Africa
21
Burkina Faso
20
Senegal
20
Russia
20
Indonesia
19
Eastern Europe and Central Asia
17
Yemen
16
Brazil
15
Pakistan
14
Sudan
13
Eswatini/ Swaziland
13
Cameroon
12
Western Pacific Region
12
Afghanistan
11
Madagascar
11
Somalia
9
Germany
9
Lebanon
9
Moldova
9
Thailand
8
Benin
8
Peru
8
Colombia
8
Georgia
8
Mali
7
Central African Republic
7
Vietnam
7
North America
7
Jordan
6
China
6
North Macedonia
6
Bolivia
6
Paraguay
6
Laos
6
Tajikistan
6
Iraq
5
Ecuador
5
Poland
5
Palestine
5
Albania
5
Southern Africa
5
Côte d’Ivoire / Ivory Coast
4
Argentina
4
Hungary
4
Libya
4
Mexico
4
Sri Lanka
4
Bhutan
4
Kyrgyzstan
4
United Kingdom
4
Morocco
3
USA
3
Saudi Arabia
3
Niger
3
Egypt
3
Papua New Guinea
3
Serbia
3
El Salvador
3
Chile
3
Fiji
3
Armenia
3
Romania
3
Iran
3
Jamaica
3
Mauritius
3
Turkey
2
Chad
2
Gambia
2
Angola
2
Canada
2
Timor Leste/ East Timor
2
Qatar
2
Bulgaria
2
Kazakhstan
2
Gabon
2
Turkmenistan
2
Japan
2
Tunisia
2
Guinea-Bissau
1
Togo
1
Malaysia
1
Switzerland
1
Burundi
1
Honduras
1
Greece
1
Guatemala
1
Nicaragua
1
Other region
1
Solomon Islands
1
Djibouti
1
Mongolia
1
Congo-Brazzaville
1
Lithuania
1
Slovakia
1
Uzbekistan
1
Australia
1
Uruguay
1
Denmark
1
France
1
Maldives
1
Norway
1
Portugal
1
Spain
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1803
Clinical Guidelines
415
Public Health
278
Women & Child Health
204
Key Resources
114
Capacity Building
88
Pharmacy & Technologies
51
Annual Report MEDBOX
2
Protection & Security
1
Toolboxes
HIV
366
COVID-19
357
TB
280
AMR
278
Mental Health
274
Pharmacy
213
NCDs
139
Caregiver
128
Conflict
108
Disability
103
Ebola
95
Rapid Response
89
NTDs
88
Planetary Health
86
Refugee
75
Global Health Education
70
Natural Hazards
45
Health Financing Toolbox
40
Zika
19
Cholera
12
Polio
12
Specific Hazards
11
Social Ethics
7
Health Financing
2
Antimicrobial agents like antibiotics are essential to treat some human and animal diseases. Microbes, such as bacteria, can develop resistance to antimicrobials meaning that a drug such as an antibiotic is no longer effective in treating the infection. The development ... resistance is caused by the incorrect use of these drugs, for example, using antibiotics (which help to treat bacteria) for viral infections like flu, or as a growth promoter in agriculture.
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best ... our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessing and treating patients, health professionals are strongly advised to use their own professional judgment, and to take into account local and national regulations and guidelines. GINA cannot be held liable or responsible for inappropriate healthcare associated with the use of this document, including any use which is not in accordance with applicable local or national regulations or guidelines.
The reader acknowledges that this report is intended as an evidence-based asthma management strategy, for the use of health professionals and policy-makers. It is based, to the best ... our knowledge, on current best evidence and medical knowledge and practice at the date of publication. When assessing and treating patients, health professionals are strongly advised to use their own professional judgment, and to take into account local or national regulations and guidelines. GINA cannot be held liable or responsible for inappropriate healthcare associated with the use of this document, including any use which is not in accordance with applicable local or national regulations or guidelines.
18 March 2020
WHO and public health authorities around the world are acting to contain the COVID-19 outbreak. However, this time of crisis is generating stress throughout the population. The considerations presented in this document have been dev...
The manual has been designed in a comprehensive manner, the aim being to provide a holistic approach to the short-term development of human resources, with a focus on primary care physicians. This is a reference manual meant for primary care physici...
This document sets out, therefore, to explain the socioeconomic value of investing in the fight against NTDs and highlights priorities for global investment attention. Our work was guided by the need not only for
additional funding and funders but ...
These consolidated guidelines on HIV testing services (HTS) bring together existing and new guidance on HTS across different settings and populations.
The World Health Organization (WHO) first released consolidated guidelines on HTS in 2015, in response to requests from Member States, national pr...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk ... CVD is an important strategy to prevent and control CVD, in addition to multisectoral population-based interventions to reduce CVD risk factors in the entire population.
Methods: We describe key public health considerations in identifying and managing individuals at high risk of CVD in LMICs.
Results: A main objective of any strategy to identify individuals at high CVD risk is to maximize the number of CVD events averted while minimizing the numbers of
individuals needing treatment. Scores estimating the total risk of CVD (e.g. ten-year risk of fatal and non-fatal CVD) are available for LMICs, and are based on the main CVD risk factors (history of CVD, age, sex, tobacco use, blood pressure, blood cholesterol and diabetes status). Opportunistic screening of CVD risk factors enables identification of persons with high CVD risk, but this strategy can be widely applied in low resource settings only if cost effective interventions are used (e.g. the WHO Package of Essential NCD interventions for primary health care in low resource settings package) and if treatment (generally for years) can be sustained, including continued availability ofaffordable medications and funding mechanisms that allow people to purchase medications without impoverishing them (e.g. universal access to health care). Thisalso emphasises the need to re-orient health systems in LMICs towards chronic diseases management.
Conclusion: The large burden of CVD in LMICs and the fact that persons with high
CVD can be identified and managed along cost-effective interventions mean that
health systems need to be structured in a way that encourages patient registration, opportunistic screening of CVD risk factors, efficient procedures for the management of chronic conditions (e.g. task sharing) and provision of affordable treatment for those with high CVD risk. The focus needs to be in primary care because that is where most of the population can access health care and because CVD programmes can be run effectively at this level.
First published in 2020, this toolkit is intended for clinicians working in acute care, managing adult and paediatric patients with acute respiratory infection, including severe pneumonia, acute respiratory distress syndrome, sepsis and septic shock. The main objective is to provide key tools for ... in the care of critically ill patients – from hospital entry to hospital discharge.
The 2022 updated version includes new tools and adapted algorithms, checklists, memory aids for COVID-19 and influenza, and the latest clinical evidence regarding clinical management of SARI. It is intended to help clinicians care for SARI patients: from epidemiology of severe acute respiratory infections, screening and triage, infection prevention and control, monitoring of patients, laboratory diagnosis, principles of oxygen therapy and different types of ventilation (invasive and non-invasive), as well as antimicrobial and immunomodulator therapies, to ethical and quality of care assessments.
The first edition is availbel in Ukrainian and Russian
Facts For Life
recommended
Handbook on pregnancy, childbirth, childhood illnesses, child development and the care of children. The handbook, Facts for Life, provides vital messages and information for mothers, fathers, other family members and caregivers and communities to ... in changing behaviours and practices that can save and protect the lives of children and help them grow and develop to their full potential.
This version of Facts for Life builds on the three previous editions, which have been helping families and communities around the world since 1989. Newborn Health has been added to the Safe Motherhood chapter, giving attention to child survival from the first stage of life. A new chapter, Child Protection, has been included, focusing attention on the actions needed to ensure children grow up in protective environments.
WHO commissioned a survey, carried out in September/October 2015, among some 10 000 members of the public in 12 countries (2 per WHO Region: Barbados, China, Egypt, India, Indonesia, Mexico, Nigeria, the Russian Federation, Serbia, South Africa, Sud...
This publication provides guidance to governments, civil society organizations (nongovernmental organizations and community-based organizations) and other partners implementing HIV prevention, care and treatment programs with key populations. This guide is designed to assist these programs in the de...
Women and Health Initiative Working Paper No. 1. Women and Health Initiative
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the...
Improving maternal health in the context of the sub-Saharan African HIV epidemic requires greater understanding of the...
The National Strategy for Natural Disaster, Prevention, Response and Mitigation to 2020, which outlines Vietnam’s main disaster risk management objectives and the National Target Program (NTP) form the overarching policy framework for disaster risk management and climate change adaption activities...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of...
The National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), 2020-2025, presents
coordinated, strategic actions that the United States Government will take in the next five years to improve the health and wellbeing of all Americans ...
31 Janaury 2021
SCORE for health data technical package. The first global assessment on the status and capacity of health information systems in 133 countries, covering 87% of the global population...
A living WHO guideline on drugs for covid-19
recommended
BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379
Rapid Recommendation and visual graph. This is the fifth version (update 4) of the living guideline (BMJ 2020;370:m3379). When citing this article, please consider adding the update number and da...
The United Nations Commission on Life-Saving Commodities (UNCLSC, 2012) defined 13 health products to end preventable deaths of woman and children. One of those 13 products is the neonatal resuscita...
